RUSSIAN MULTICENTER EPIDEMIOLOGICAL STUDY "MEDICAL-DIAGNOSTIC TACTICS OF MANAGEMENT OF PREGNANT WOMEN WITH ARTERIAL HYPERTENSION IN RUSSIA DIALOGUE II: ANALYSIS OF RESULTS AND WAYS TO SOLVING PROBLEMS
- Authors: Tkacheva O1, Bevz A1, Chuhareva N1, Novikova I1, Sharashkina N1, Tkacheva O.N.1, Bevz A.Y.1, Chukhareva N.A.1, Novikova I.M.1, Sharashkina N.V.1
-
Affiliations:
- Issue: No 9 (2010)
- Pages: 44-51
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278431
- ID: 278431
Cite item
Full Text
Abstract
About the authors
O Tkacheva
A Bevz
N Chuhareva
I Novikova
N Sharashkina
Ol'ga Nikolaevna Tkacheva
Alina Yur'evna Bevz
Natal'ya Aleksandrovna Chukhareva
Irina Mikhaylovna Novikova
Natal'ya Viktorovna Sharashkina
References
- Шехтман М.М. Руководство по экстрагенитальной патологии у беременных. М., 2008. 113-48.
- Roberts JM, Pearson G, Cutler J, et al. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 2003;41:437-45.
- Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caibbean. Brit J Obstet Gynaecol 1992;99(7):547-53.
- Health Canada. Special report on maternal mortality and severe morbidity in Canada - Enhanced surveillance: the path to prevention. Ottawa: Minister of Public Works and Government Services Canada; 2004.
- Why mothers die 2000-2002. The sixth report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London: RCOG Press; 2004.
- Серов В.Н., Фролова О.Г., Токова З.З. Основные причины материнской смертности в последние 5 лет // Проблемы беременности. 2001. .№ 3. C. 15-9.
- Rodie VA, Freeman DJ, Sattar N, et al. Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis 2004;175(2):189-202.
- ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. No. 33, January 2002. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;99:159-67.
- Макаров О.В., Николаев Н.Н., Волкова Е.В. и соавт. Тактика ведения беременных с различными формами артериальной гипертензии. Материалы 8-го Всероссийского научного форума "Мать и дитя" 2006. С. 149.
- Сидорова И.С. Гестоз. М., 2003. С. 41.
- Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:1-22.
- Podymow Т, August Ph. Update on the Use of Antihypertensive Drugs in Pregnancy. Hypertension 2008;51:960-9.
- Lowe SA, Brown MA, Dekker G, et al. Guidelines for the management of hypertensive disorders of pregnancy. Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) 2009;49(3):242-6.
- Diagnostik und therapie hypertensiver schwangerschaftserkrankungen Deutsche Gesellschaft furGynakologie und Geburtshilfe (DGGG), Arbeitsgemeinschaft Schwangerschaftshochdruck / Gestose 2008;24.
- Hypertension Guideline Committee and approved by the Executive and Council of the Society of Obstetricians and Gynaecologists of Canada. Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy. J Obstet Gynaecol Can 2008;30(3):1-48.
- Рабочая группа по лечению артериальной гипертонии Европейского общества гипертонии (ESH) и Европейского общества кардиологов (ESC) Рекомендации 2007 года по лечению артериальной гипертонии // Рациональная Фармакотерапия в Кардиологии 2008. № 1-2. C. 51-3.
- ESC Expert Consensus Document on Management of Cardiovascular Diseases during Pregnancy. European Heart Journal 2003;24(8):761-81.
- North RA, Taylor RS, Schellenberg JC. Evaluation of a definition of pre-eclampsia. Br J Obstet Gynaecol 1999;106:767-73.
- Levine RJ, Ewell MG, Hauth JC, et al. Should the definition of preeclampsia include a rise in diastolic blood pressure of >/=15 mm Hg to a level Am J Obstet Gynecol 2000;183(4):787-92.
- Martin JN Jr, Thigpen BD, Moore RC, et al. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005;105:246-54.
- Helewa M, Heaman M, Robinson MA, et al. Community-based home-care program for the management of pre-eclampsia: an alternative. CMAJ 1993;149:829-34.
- Abalos E, Duley L, Steyn D, et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2007;24(1):CD002252.
- Magee LA, Ornstein MP, von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ 1999;318:1332-6.
- Dadelszen P, Ornstein MP, Bull SB, et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000;355:87-92.
- Dadelszen P, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis. J Obstet Gynaecol Can 2002;24(12):941-5.
- Magee LA, von Dadelszen P, Chan S, et al. The CHIPS Pilot Trial (Control of Hypertension In Pregnancy Study). J Obstet Gynaecol Can 2006;28:416.
- Макаров О.В., Николаев Н.Н., Волкова Е.В. и соавт. Параметры центральной гемодинамики в дифференциальной диагностике различных форм артериальной гипертензии у беременных. Материалы 8-го Всероссийского научного форума "Мать и дитя" 2006. 149.
- Cockburn J, Moar VA, Ounsted M, et al. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982;1:647-9.
- Magee LA, Schick B, Donnenfeld AE, et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 1996;174:823-8.
- Bortolus R, Ricci E, Chatenoud L, et al. Nifedipine administered in pregnancy: effect on the development of children at 18 months. Br J Obstet Gynaecol 2000;107:792-4.
- Серов В.Н. Гестоз: современная лечебная тактика // Фарматека. 2004. № 1. C. 67-71.
- Макаров О.В., Николаев Н.Н., Волкова Е.В. Артериальная гипертензия у беременных. Только ли гестоз? М., 2006. С. 174.
- Groves TD, Corenblum B. Spironolactone therapy during human pregnancy. Am J Obstet Gynecol 1995;172:1655-6.
- Kisters K, et al. Membrane, intracellular, and plasma magnesium and calcium concentrations in preeclampsia Am J Hypertens 2000;13(7):765-9.
- Qi Q, et al. Magnesium and calcium concentrations of peripheral serum and mononuclear cells in patients with pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi 1997;32(1):15-8.
- Li S, Tian H. Oral low-dose magnesium gluconate preventing pregnancy induced hypertension. 1997 Zhonghua Fu Chan Ke Za Zhi 1997;32(10):613-5.
- Верткин А.Л., Ткачева О.Н., Мурашко Л.Е. и соавт. Обмен магния и терапия препаратами магния при гестозе // Акушерство, Гинекология, Педиатрия. 2005. № 2. C. 98.
- Верткин А.Л., Ткачева О.Н., Ткачева О.М. и соавт. Некоторые аспекты применения препаратов магния при беременности // Проблемы репродукции. 2005;.№ 4. C. 57-63.
- Makrides M, Crowther CA. Magnesium supplementation in pregnancy. Cochrane Database Syst Rev 2001;(4):CD000937.
- Hanssens M, Keirse MJ, Vankelecom F, et al. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 1991;78:128-35.
- Buttar HS. An overview of the influence of ACE inhibitors on fetal placental circulation and perinatal development. Mol Cell Biol 1997;176:61-71.
- Saji H, Yamanaka M, Hagiwara A, et al. Losartan and fetal toxic effects. Lancet 2001;357:363.
- Centers for Disease Control and Prevention. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy - United States, Canada, and Israel, 1987-1995. JAMA 1997;277:1193-4.
- Briggs GG, Nageotte MP. Fatal fetal outcome with the combined use of valsartan and atenolol. Ann Pharmacother 2001;35:859-61.
- Lambot MA, Vermeylen D, Noel JC. Angiotensin-II-receptor inhibitors in pregnancy. Lancet 2001;357:1619-20.
- Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006;354:2443-51.